Resistance studies of Candida albicans, with special reference to two patients subjected to prolonged antimycotic treatment.
D000293:Adolescent; D000666:Amphotericin B / Q000627:therapeutic use; D002179:Candidiasis, Cutaneous / Q000150:complications* / Q000188:drug therapy; D002180:Candidiasis, Oral / Q000150:complications* / Q000188:drug therapy; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000150:complications*; D008875:Middle Aged; D009761:Nystatin / Q000627:therapeutic use; D009912:Oral Manifestations; D012507:Sarcoidosis / Q000150:complications*
D009761:Nystatin; D000666:Amphotericin B